Wednesday - May 21, 2025
Anti-Cancer Drugs Issues Research Articles in July 2024 Edition
June 03, 2024
LONDON, England, June 3 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its July 2024 edition (Vol. 35, Issue 6):

Pre-Clinical Reports:

* USP3 promotes cisplatin resistance in non-small cell lung cancer . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products